Location History:
- Kelkheim, Taunus, DE (1977)
- Kelkheim, DE (1979 - 1980)
Company Filing History:
Years Active: 1977-1980
Title: Bernd Knabe: Innovator in Pharmaceutical Chemistry
Introduction
Bernd Knabe is a notable inventor based in Kelkheim (Taunus), Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of valuable antibiotics. With a total of 4 patents to his name, his work has had a considerable impact on medical science.
Latest Patents
Among his latest patents, Bernd Knabe has developed [(2-Amino-thiazol-4-yl)glyoxylamido]-cephem derivatives. These cephem derivatives are characterized by a specific formula where R¹ denotes hydrogen or low-molecular alkoxy, R² denotes hydrogen, and X can be sulfur, oxygen, or CH₂. These compounds are recognized for their effectiveness against Gram-positive and Gram-negative infections, particularly against penicillinase-forming staphylococci. Another significant patent involves thiazolidine derivatives, which possess valuable pharmaceutical properties and can be prepared in non-toxic acid addition salt forms. These compounds are also utilized as medicines, showcasing their importance in therapeutic applications.
Career Highlights
Bernd Knabe is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Hoechst has allowed him to focus on innovative solutions in drug development, contributing to advancements in antibiotic therapies.
Collaborations
Throughout his career, Bernd has collaborated with esteemed colleagues such as Hans-Jochen Lang and Dieter Bormann. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
In summary, Bernd Knabe is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important antibiotics. His contributions continue to influence the field and improve medical treatments.